| CPC A61B 17/0057 (2013.01) [A61L 24/02 (2013.01); C08L 71/02 (2013.01); A61B 2017/00495 (2013.01); A61B 2017/00526 (2013.01); A61B 2017/00561 (2013.01); A61B 2017/0065 (2013.01); A61B 2017/00871 (2013.01); A61B 2017/00884 (2013.01); A61B 2017/00889 (2013.01); A61B 2017/00893 (2013.01); A61B 2017/00898 (2013.01); A61B 2017/00951 (2013.01); A61B 2017/22067 (2013.01); A61B 2017/22069 (2013.01); A61B 90/90 (2016.02)] | 41 Claims |
|
1. A sealant for sealing a puncture through tissue, comprising:
an elongate first section including a proximal end, a distal end, and a cross-section sized for delivery into a puncture through tissue, the first section formed from a freeze-dried hydrogel that expands when exposed to physiological fluid within the puncture; and
a second section fused to and extending from the distal end of the first section, the second section formed from non-freeze-dried, non-crosslinked hydrogel precursors, the precursors remaining in an unreactive state until exposed to an aqueous physiological environment, whereupon the precursors undergo in-situ crosslinking with one another to provide an adhesive layer bonded to the first section.
|